News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xencor Inc
(NQ:
XNCR
)
19.85
+0.37 (+1.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Xencor Inc
< Previous
1
2
3
Next >
Xencor Announces Upcoming Change to Board of Directors
October 04, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
September 12, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Announces Pricing of $175 Million Public Offering of Common Stock
September 11, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Announces Proposed Public Offering of Common Stock
September 10, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs
September 09, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024
September 06, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Second Quarter 2024 Financial Results
August 05, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Regains CD20 x CD3 Bispecific T-Cell Engager
June 13, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Reports First Quarter 2024 Financial Results
May 09, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Appoints Bart Cornelissen as Chief Financial Officer
April 09, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at Upcoming Investor Conferences
February 28, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
February 20, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Xencor, Inc.
Via
Business Wire
Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy
January 02, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million
November 07, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting
November 03, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023
October 31, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Announces Planned Retirement of Chief Financial Officer John Kuch
October 26, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present Multiple Posters at the SITC Annual Meeting
September 27, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors
September 19, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Second Quarter 2023 Financial Results
August 03, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023
July 27, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 Congress
May 30, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Reports First Quarter 2023 Financial Results
May 08, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023
May 01, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Appoints Nancy Valente, M.D., as Chief Development Officer
April 26, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023
April 17, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present Preclinical Data from Novel XmAb® CD28 Bispecific Antibody Programs at the American Association for Cancer Research Annual Meeting 2023
March 14, 2023
From
Xencor, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.